Navigation Links
Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
Date:8/19/2013

LEXINGTON, Mass., Aug. 19, 2013 /PRNewswire/ -- Virtify, Inc., a leading innovator in content and regulatory information management solutions for the life science industry, today announced Indiana University has signed an enterprise-level contract for its Clinical Trial Registration & Results (CTRR) disclosure software. Indiana University will utilize Virtify's CTRR to fulfill their regulatory obligations by disclosing their clinical trial information to the National Institute of Health's clinicaltrials.gov system. The system is funded and being implemented by the Indiana Clinical and Translational Sciences Institute (CTSI), a statewide partnership among IU, Purdue University and the University of Notre Dame funded by the National Institutes of Health.

(Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO )

"Indiana CTSI will partner with Virtify to help automate the complex clinical trial disclosure processes within the institution in order to fulfill its regulatory requirements. We're pleased to be working with Virtify to develop solutions that will help to reduce the effort it takes to publish the trial information to clinicaltrials.gov," said Richard Kovacs, M.D., associate dean for clinical research at the Indiana University School of Medicine and associate director of the Indiana CTSI.

The old paradigm for managing disclosure throughout the clinical trial process has changed. In the U.S. alone, submissions to www.clinicaltrials.gov are bound by 2,700 unique rules regarding clinical trial registration and 2,500 additional rules for results postings. Many academic and research organizations manage clinical trial disclosure manually, increasing compliance risk and costs.

Virtify's CTRR streamlines and automates the mandatory registration and c
'/>"/>

SOURCE Virtify, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
2. BioCrossroads Commemorates Decade of Collaboration, Success for Indiana Life Sciences Sector
3. Positron Accepts Economic Incentives Offer From The City Of Gary, Indiana For $30 Million Towards 70 MeV Cyclotron Project
4. Its Indiana State Fair Season: New BioCrossroads Report Emphasizes Opportunities in Food and Agriculture Innovation
5. Indiana’s Life Sciences Industry Economic Impact Tops $50 billion
6. Indigo Biosystems Among “Best Places to Work” in Indiana
7. StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500
8. Nanounity Announces New Characterization Tools for the 2013 Microscopy & Microanalysis Annual Meeting in Indianapolis, August 4-8
9. Arizona State University engineers aim to improve performance of technology in extreme environments
10. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
11. Causes of Gulf War Illness are complex and vary by deployment area -- Baylor University study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 ...   2011 von der Assistance Publique - ... initiiert., Sie ist eine französische, gemeinschaftliche, randomisierte ... Patienten rekrutiert wurden. Verglichen werden Patienten mit ... Yttrium-90 Harz-Mikrosphären oder Sorafenib behandelt wurden. Die ...
(Date:3/5/2015)... New York (PRWEB) March 05, 2015 ... veterans to be able to get an Advanced Semen ... money, stress, blaming and guessing are all risk factors ... assuming the woman is the source of the infertility. ... female. LifeCell Dx has the simplest, least complicated ...
(Date:3/5/2015)... Park, NC (PRWEB) March 05, 2015 ... announced that Pierre Noel, M.D., Professor of Medicine, ... to the Company’s Board of Directors. ... “We are extremely fortunate to have Dr. Noel, ... country’s leading healthcare organization, join Entegrion’s Board. His ...
(Date:3/5/2015)... -- In response to the incorrect assertions by LD, distributed ... on February 12, 2015. Impeto Medical SAS and its ... their SUDOSCAN® devices have been proven to provide accurate ... have the courts decide this dispute rather than the ... written by Key Opinion Leaders, published by significant peer-reviewed ...
Breaking Biology Technology:Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 2Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 3Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 4Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 5Behandlung von primärem Leberkrebs: SARAH-Studie schließt Rekrutierung ab, Ergebnisse werden für Ende 2016 erwartet 6LifeCell Dx Offers New Option to Veterans with Infertility 2LifeCell Dx Offers New Option to Veterans with Infertility 3Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2
... ... Vein and Skin Care Center. Tokyo Vein Clinic visited , for a close up look at ... back to patients in Japan. , ... June 16, 2010 -- The Japanese have a long history of being on the cutting edge. ...
... ... found dead four days after receiving the Gardasil vaccine has filed an amicus ... asked to bar lawsuits against manufacturers of defectively designed vaccines. The mother ... a lessened incentive to produce a safe vaccine and public trust in the ...
... ... ... The American Medical Writers Association named medical writer, Rita Buckley, Writer/Owner of medical ... Medical Communication. She received the awards for The Lehman Series Expert Panel on Weight ...
Cached Biology Technology:OnychoLase Laser Nail Centers Making a Global Impact, By Bringing Western Medicine To The East 2Supreme Court Amicus Brief Filed Opposing Lawsuit Protection for Manufacturers of Defectively Designed Vaccines 2Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication 2Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication 3
(Date:2/5/2015)... North Carolina , 5. Februar 2015 ... Jahr als spezialisiertes Logistikunternehmen und hat eine ... einzige klinische Logistikfirma (Clinical Logistics Organization – ... der neuen Kampagne lautet First , ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... --  Epic Sciences , a precision diagnostics company dedicated to ... Prahalad , Ph.D., president and CEO, is scheduled to present ... Silicon Valley, which is taking place at the Computer History ... January 26-28, 2015. Dr. Prahalad will give ... year, Epic Sciences was a finalist in the PMWC,s Most ...
(Date:2/5/2015)... , Jan. 27, 2015   Marvin ... globally deployed, innovative test solutions for military, ... delivery of its TS-323 GENASYS Test ... Company (LMSSC). GENASYS is a high-performance PXI-based ... mission-critical applications that require performance functional testing. ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... 2012 In 2012 Wiley-Blackwell, the Scientific, Technical, Medical, ... Inc., will begin publishing 44 titles new to its ... published in collaboration with societies or other organizations. ... the course of 2012 include Advanced Healthcare Materials ...
... the aid of light: this is made possible ... of neurobiological processes with unprecedented spatial and temporal ... light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin ... through an interdisciplinary approach. The researchers report on ...
... drug may be useful in fighting malaria, researchers report in ... protozoa, the drug readily crosses into the red blood cells ... works at very low concentrations with no observed toxicity to ... of the National Academy of Sciences . The researchers ...
Cached Biology News:Wiley-Blackwell adds 44 titles to journal publishing program in 2012 2Optogenetic tool elucidated 2Modified bone drug kills malaria parasite in mice 2
... dihydrochloride) is a fluorescent counterstain ... in color. The bright blue ... red fluorochromes such as rhodamine, ... DAPI can be used for ...
... sets of glass plates, bar clamp, and ... features of these units are:, safety interlock ... reservoirs , upper and lower reservoirs have ... safe disposal of buffer solutions , leveling ...
... P450 (CYP450) metabolite postulated to play an ... vasculature. In rat cerebral microvessels, 20-HETE is ... 20-HETE is excreted mainly as the glucuronide ... pg/ml in human urine) is about 10-fold ...
... sensitive silver stain. Reproducible ... baths or reversers needed. ... polysaccharides. Linear protein-to-stain color ... multiple gels per tray. ...
Biology Products: